| 2026-09-22 | 8-K | 10.1 | Form of Capped Call Confirmation. |
|---|
| 2026-02-17 | 10-K | 10.37 | CEO PSU Agreement, Absolute Stock Price Grant (2021 Stock Plan) |
|---|
| 2026-02-17 | 10-K | 10.36 | Transition and Release Agreement between Halozyme Therapeutics, Inc. and Nicole LaBrosse, dated November 18, 2025 |
|---|
| 2026-02-17 | 10-K | 10.7 | Amendment No. 3 to the Credit Agreement |
|---|
| 2025-11-12 | 8-K | 10.1 | Form of Capped Call Confirmation. |
|---|
| 2025-05-06 | 10-Q | 10.2 | Form of 2025 Relative TSR Performance Stock Units Agreement (2021 Stock Plan) (filed herewith) |
|---|
| 2025-05-06 | 10-Q | 10.1 | Form of 2025 Deal/Nomination Performance Stock Units Agreement (2021 Stock Plan) (filed herewith) |
|---|
| 2024-08-06 | 10-Q | 10.1 | Form of Restricted Unit Agreement (2021 plan updated June 2024) (filed herewith) |
|---|
| 2024-02-20 | 10-K | 10.28 | Severance Policy |
|---|
| 2023-08-08 | 10-Q | 10.5 | Letter Agreement Amending Exercise Period for Employee Option (filed herewith) |
|---|
| 2023-08-08 | 10-Q | 10.4 | Form of Director Stock Option Agreement (2021 Plan) (filed herewith) |
|---|
| 2023-08-08 | 10-Q | 10.3 | Form of Restricted Unit Agreement (2021 Plan Sell-to-Cover updated May 2023) (filed herewith) |
|---|
| 2023-08-08 | 10-Q | 10.2 | Form of Restricted Stock Unit Agreement (2021 Plan updated May 2023) (filed herewith) |
|---|
| 2023-08-08 | 10-Q | 10.1 | Form of Stock Option Agreement (2021 Plan updated May 2023) (filed herewith) |
|---|
| 2023-05-09 | 10-Q | 10.1 | Amendment No. 2 to the Credit Agreement (filed herewith) |
|---|
| 2022-11-08 | 10-Q | 10.4 | Halozyme Therapeutics, Inc. 2021 Employee Stock Purchase Plan |
|---|
| 2022-11-08 | 10-Q | 10.3 | Severance Policy. |
|---|
| 2022-08-19 | 8-K | 10.1 | Amendment No. 1 to the Credit Agreement. |
|---|
| 2022-08-18 | 8-K | 10.1 | Form of Capped Call Confirmation. |
|---|
| 2022-05-24 | 8-K | 10.2 | Security Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors and Bank of America N.A. |
|---|
| 2022-05-24 | 8-K | 10.1 | Credit Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors, Bank of America N.A. and each of those additional Lenders that are a party to such agreement. |
|---|
| 2022-05-10 | 10-Q | 10.1 | Agreement for Assignment and Assumption of Lease, Del Mar Corporate Centre I Office Lease and First Amendment to Office Lease |
|---|
| 2022-02-22 | 10-K | 10.39 | Halozyme Therapeutics, Inc Directors Deferred Equity Compensation Plan |
|---|
| 2022-02-22 | 10-K | 10.38 | Halozyme Therapeutics, Inc. Non Qualified Deferred Compensation Plan Adoption Agreement |
|---|
| 2021-12-29 | 8-K | 10.2 | Security Agreement, dated as of December 23, 2021, by and among the Company, the Guarantor and Bank of America N.A. |
|---|
| 2021-12-29 | 8-K | 10.1 | Credit Agreement, dated as of December 23, 2021, by and among the Company, the Guarantor, Bank of America N.A. and each of those additional Lenders that are a party to such agreement. |
|---|
| 2021-08-09 | 10-Q | 10.9 | Form of Restricted Stock Units Agreement for Irish Participants (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.8 | Form of Director Restricted Stock Units Agreement (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.7 | Form of Performance Stock Units Agreement (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.6 | Form of Restricted Stock Award Agreement (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.5 | Form of Restricted Stock Units Agreement (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.4 | Form of Restricted Stock Units Agreement for Officers (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.3 | Form of Stock Option Agreement (2021 Stock Plan) |
|---|
| 2021-05-05 | 8-K | 10.2 | Halozyme Therapeutics, Inc. 2021 Stock Plan |
|---|
| 2021-05-05 | 8-K | 10.1 | Halozyme Therapeutics, Inc. 2021 Employee Stock Purchase Plan |
|---|
| 2021-02-23 | 10-K | 10.26 | Form of PSU Agreement |
|---|
| 2020-08-10 | 10-Q | 10.1 | EXHIBIT 10.1 FORM OF PSU AGREEMENT |
|---|
| 2019-08-06 | 10-Q | 10.1 | EXHIBIT 10.1 THIRD AMENDMENT TO LOAN AGREEMENT |
|---|
| 2018-12-13 | 8-K | 10.1 | Halozyme Therapeutics, Inc. Severance Policy |
|---|
| 2018-11-06 | 10-Q | 10.1 | Halozyme Therapeutics, Inc. Severance Policy |
|---|
| 2018-05-10 | 10-Q | 10.2 | Second Amendment to Lease (11404 and 11408 Sorrento Valley Road), dated March 23, 2018 |
|---|
| 2018-05-10 | 10-Q | 10.1 | Second Amendment to Amended and Restated Lease (11388 Sorrento Valley Road), dated March 23, 2018 |
|---|
| 2018-04-06 | 8-K | 10.1 | Halozyme Therapeutics, Inc. 2011 Stock Plan, as proposed to be amended |
|---|
| 2018-02-20 | 10-K | 10.34 | Consent, Release, and Second Amendment to Loan and Security Agreement, dated November 21, 2017 |
|---|
| 2017-07-05 | 8-K | 10.3 | Second Modification to Lease (11436 Sorrento Valley Road), dated June 30, 2017 |
|---|
| 2017-07-05 | 8-K | 10.2 | First Amendment to Lease (11404 and 11408 Sorrento Valley Road), dated June 30, 2017 |
|---|
| 2017-07-05 | 8-K | 10.1 | First Amendment to Amended and Restated Lease (11388 Sorrento Valley Road), dated June 30, 2017 |
|---|
| 2017-02-28 | 10-K | 10.33 | Consent, Release, and First Amendment to Loan and Security Agreement, dated December 21, 2016 |
|---|
| 2017-02-28 | 10-K | 10.22 | Form of Restricted Stock Units Agreement (2011 Plan - grants made on or after 2/22/2017) |
|---|
| 2016-08-09 | 10-Q | 10.2 | Loan and Security Agreement, dated June 7, 2016 |
|---|
| 2016-02-29 | 10-K | 10.35 | Credit Agreement, dated December 30, 2015 |
|---|
| 2016-02-29 | 10-K | 10.34 | Consent, Release and Third Amendment to Amended and Restated Loan and Security Agreement, dated December 28, 2015 |
|---|
| 2015-11-09 | 10-Q | 10.4 | Form of Restricted Stock Units Agreement (2011 Stock Plan) |
|---|
| 2015-11-09 | 10-Q | 10.3 | Form of Restricted Stock Award Agreement (2011 Stock Plan) |
|---|
| 2015-11-09 | 10-Q | 10.2 | Form of Stock Option Agreement (2011 Stock Plan) |
|---|
| 2015-11-09 | 10-Q | 10.1 | Form of Amended and Restated Change in Control Agreement |
|---|
| 2015-08-10 | 10-Q | 10.3 | Form of Restricted Stock Award Agreement (2011 Stock Plan) |
|---|
| 2015-08-10 | 10-Q | 10.2 | Form of Restricted Stock Units Agreement (2011 Stock Plan) |
|---|
| 2015-08-10 | 10-Q | 10.1 | Halozyme Therapeutics, Inc. 2011 Stock Plan, as amended through May 6, 2015 |
|---|
| 2015-03-02 | 10-K | 10.39 | Second Amendment to Amended and Restated Loan and Security Agreement, dated January 23, 2015 |
|---|
| 2014-08-11 | 10-Q | 10.1 | LOAN AMENDMENT |
|---|
| 2014-05-12 | 10-Q | 10.2 | SEPARATION AGREEMENT |
|---|
| 2014-02-28 | 10-K | 10.38 | AMENDED LOAN AND SECURITY AGREEMENT |
|---|
| 2014-02-28 | 10-K | 10.26 | CHANGE IN CONTROL AGREEMENT WITH CEO |
|---|
| 2013-05-08 | 10-Q | 10.1 | LEASE MODIFICATION |
|---|
| 2013-03-01 | 10-K | 10.47 | FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT AND DISBURSEMENT LETTER |
|---|
| 2013-03-01 | 10-K | 10.46 | LOAN AND SECURITY AGREEMENT AND DISBURSEMENT LETTER |
|---|
| 2013-03-01 | 10-K | 10.45 | LEASE (11436 SORRENTO VALLEY) |
|---|
| 2013-03-01 | 10-K | 10.33 | FORM OF CHANGE IN CONTROL AGREEMENT WITH OFFICER |
|---|
| 2013-03-01 | 10-K | 10.32 | FORM OF AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT WITH OFFICER |
|---|
| 2013-03-01 | 10-K | 10.31 | AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT WITH CEO |
|---|
| 2011-06-16 | 8-K | 10.2 | Lease (11404 and 11408 Sorrento Valley Road), effective as of June 10, 2011. |
|---|
| 2011-06-16 | 8-K | 10.1 | Amended and Restated Lease (11388 Sorrento Valley Road), effective as of June 10, 2011 |
|---|
| 2011-05-06 | 8-K | 10.5 | Form of Restricted Stock Award Agreement (2011 Stock Plan) |
|---|
| 2011-05-06 | 8-K | 10.4 | Form of Restricted Stock Units Agreement (2011 Stock Plan) |
|---|
| 2011-05-06 | 8-K | 10.3 | Form of Stock Option Agreement for Executive Officers (2011 Stock Plan) |
|---|
| 2011-05-06 | 8-K | 10.2 | Form of Stock Option Agreement (2011 Stock Plan) |
|---|
| 2011-05-06 | 8-K | 10.1 | Halozyme Therapeutics, Inc. 2011 Stock Plan |
|---|
| 2011-03-11 | 10-K | 10.36 | SEPARATION AGREEMENT |
|---|
| 2011-01-10 | 8-K | 10.1 | Termination Agreement between Halozyme Inc., Baxter Healthcare Corporation and Baxter Healthcare S.A., effective as of January 7, 2011. |
|---|
| 2009-08-07 | 10-Q | 10.20 | EXHIBIT 10.20 |
|---|
| 2009-08-07 | 10-Q | 10.18 | EXHIBIT 10.18 |
|---|
| 2009-08-07 | 10-Q | 10.17 | EXHIBIT 10.17 |
|---|